Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1699-3055
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy ; day:13 ; month:4 ; year:2017 ; pages:1-8
Clinical and translational oncology ; (13.4.2017), 1-8
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Aparicio, L. M. A.
- Beteiligte Personen und Organisationen
-
Fernandez, I. P.
Cassinello, J.
SpringerLink (Online service)
- DOI
-
10.1007/s12094-017-1657-7
- URN
-
urn:nbn:de:1111-2017042915355
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aparicio, L. M. A.
- Fernandez, I. P.
- Cassinello, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti‐Tumor Immunity
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
Exploiting innate immunity for cancer immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
MAPK-triggered chromatin reprogramming by histone deacetylase in plant innate immunity
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti‐Tumor Immunity
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
Exploiting innate immunity for cancer immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
MAPK-triggered chromatin reprogramming by histone deacetylase in plant innate immunity
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti‐Tumor Immunity
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
Exploiting innate immunity for cancer immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
MAPK-triggered chromatin reprogramming by histone deacetylase in plant innate immunity
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy